InvestorsHub Logo
Followers 35
Posts 6901
Boards Moderated 1
Alias Born 04/04/2020

Re: Nukemtiltheyglow post# 426881

Sunday, 07/14/2024 3:55:48 PM

Sunday, July 14, 2024 3:55:48 PM

Post# of 427087
Nuke, No one is going to go after doctors or patients for direct infringement. If Amarin has found a way to force the generic product out of the US market doctors can't prescribe it. Generic producers, PBM's, and insurance providers are the three primary targets. It looks like Amarin has chosen to target the source.
Sleven,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News